NCT00757874View on ClinicalTrials.gov

Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus

PHASE2CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

January 31, 2010

Conditions

Vulvar Lichen Sclerosus

Interventions

DRUG

Tacrolimus cream

0.5 g per day at bed time for 3 months or less.

DRUG

Clobetasol cream

0.5 gram each day at bed time during 3 months or less.

Trial Locations (1)

H3P 3N5

CHU Sainte-Justine, Montreal

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Deana Funaro

OTHER